OnCo
trialsTrialCompleted

Phase II Study of Lenalidomide and Eltrombopag in Patients With Symptomatic Anemia

A phase 2 trial of Eltrombopag and Lenalidomide in Leukaemia, run by Albert Einstein College of Medicine, completed.